RICTOR and squamous cell lung carcinoma: The RICTOR amplification in squamous cell lung carcinoma was linked with a bad prognosis and short survival.87 Further, this study showed the sensitivity of mTORC1/2 inhibitors against RICTOR-amplified lung cancer cells.